Assistant Professor in Clinical pathology, Inha University Hospital
2019.03
~ 2021.02
Clinical Assistant Professor in Clinical pathology, Inha University Hospital
2017.03
~ 2019.02
Clinical Assistant Professor in Clinical pathology, The Catholic University of Korea Seoul St. Mary's Hospital
2012.03
~ 2015.02
Fellow, The Catholic University of Korea Seoul St. Mary's Hospital
2008.03
~ 2012.02
Resident, Inha University Hospital
2006.03
~ 2007.02
Intern, Konkuk University Hospital
Professional Activities
Honors
Research & Publications
2019
CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia. Jang W, Park J, Kwon A, Choi H, Kim J, Lee GD, Han E, Jekarl DW, Chae H, Han K, Yoon JH, Lee S, Chung NG, Cho B, Kim M, Kim Y. Exp Mol Med. 2019 Jan 11;51(1):4.
2019
Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea. Jang W, Kim Y, Han E, Park J, Chae H, Kwon A, Choi H, Kim J, Son JO, Lee SJ, Hong BY, Jang DH, Han JY, Lee JH, Kim SY, Lee IG, Sung IK, Moon Y, Kim M, Park JH. Ann Lab Med. 2019 May;39(3):299-310
2018
Hereditary dehydrated stomatocytosis with splicing site mutation of PIEZO1 mimicking myelodysplastic syndrome diagnosed by targeted next-generation sequencing. Park J, Jang W, Han E, Chae H, Yoo J, Kim Y, Kim YJ, Kim M. Pediatr Blood Cancer. 2018 Jul;65(7):e27053.
2017
Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory. Chae H, Kim J, Lee GD, Jang W, Park J, Jekarl DW, Oh YS, Kim M, Kim Y. Clin Chim Acta. 2017 Jan;464:128-135.
2016
Identification of small marker chromosomes using microarray comparative genomic hybridization and multicolor fluorescent in situ hybridization. Jang W, Chae H, Kim J, Son JO, Kim SC, Koo BK, Kim M, Kim Y, Park IY, Sung IK. Mol Cytogenet. 2016 Aug 8;9:61.
2016
A twin sibling with Prader-Willi syndrome caused by type 2 microdeletion following assisted reproductive technology: A case report. Han JY, Park J, Jang W, Chae H, Kim M, Kim Y. Biomed Rep. 2016 Jul;5(1):18-22.
2016
Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia. Jang W, Yoon JH, Park J, Lee GD, Kim J, Kwon A, Choi H, Han K, Nahm CH, Kim HJ, Min WS, Kim M, Kim Y. Blood Cancer J. 2016 Jan 15;6:e387.
2016
Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia. Jang W, Yoon JH, Park J, Lee GD, Kim J, Kwon A, Choi H, Han K, Nahm CH, Kim HJ, Min WS, Kim M, Kim Y. Blood Cancer J. 2016 Jan 15;6:e387.
2014
Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma. Jang W, Kim M, Lee JW, Chung NG. Int J Hematol. 2014 Mar;99(3):213-4.
2013
Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime. Jang W, Park YJ, Park KG, Yu J. J Antimicrob Chemother. 2013 Oct;68(10):2282-5.
